[Radioprogestins. Their clinical use].
It was obtained by synthesis a radioprogestin-iodine-131 and proved in two patients with hormono-dependent meningioma to progesterone with very good results in the scan of cerebral tumours localization; and in one patient in the treatment of this kind of tumour. No radiotoxicity or intolerance was present until today in six month of follow-up of this preliminary uses of radioprogestin in cerebral tumours hormono-dependent to progesterone; so it is proposed the use of this new radiopharmaco for the diagnosis and treatment of this tumours.
Skromne Kadlubik
G
G
Depto. de Fisiología, Fac. Medicina, UNAM, México, D.F.
D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008577:Meningeal Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy; D008579:Meningioma / Q000000981:diagnostic imaging / Q000532:radiotherapy; D011372:Progestins / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D012074:Remission Induction
D007457:Iodine Radioisotopes; D011372:Progestins
Radioprogestinas. Su utilidad clínica.